News

Join us at CTSS summit in Munich!

07. May 2025

Medical imaging plays an increasingly vital role in clinical research – and we’re proud to be leading the way with innovative imaging solutions.

Joins us to discuss this and other topics at the 19th Clinical Trials Strategic Summit (CTSS) 2025 in Munich, where our COO, Dr. Julia Müller, will represent us.

At mediri, we specialize in advanced medical imaging solutions that support clinical trials from early-phase research to multi-center studies. Our expertise spans image data management, centralized image reading, and AI-assisted analysis, helping to ensure precision, consistency, and regulatory compliance in clinical research.
The CTSS summit is a fantastic opportunity to exchange ideas, explore innovations, and shape the future of clinical trials together.

We’re looking forward to insightful discussions and new collaborations.
Let’s connect in Munich!

1500 followers on Linkedin

28. April 2025

We’ve reached 1500 followers! 

We are incredibly grateful for your support and thrilled to have such an amazing community. Thank you for being a part of our journey! We look forward to achieving even greater things with you by our side!

mediri is your dedicated partner for efficient and reliable imaging studies. With extensive experience in clinical studies, cutting-edge software, and imaging expertise, we provide comprehensive solutions from site management and quality control to central evaluation. Our cloud platform, mTRIAL, ensures seamless data exchange, top-notch data security in Germany, and AI-supported workflows tailored to your study. We drive clinical studies forward and bring new diagnostic techniques to patients, fueled by scientific curiosity and interdisciplinary project experience.

Welcome Tewele

24. April 2025

We are delighted to have Tewele Weletnsea TAREKE , Ph.D. student for the BosomShield project with us for the next four weeks, enriching our mediri research team. Tewele is here as part of the BosomShield project, working on advancing AI-based radiomics and making meaningful contributions to the future of precision oncology.
Welcome aboard, Tewele! We look forward to the innovative insights and progress you’ll bring to our team. 

Exciting News!

17. April 2025

We are thrilled about the market approval of Lecanemab in the EU, marking a promising breakthrough for millions affected by Alzheimer’s disease. Early detection is crucial, and in this field, our ASL team is at the forefront of research. Upcoming observational studies can be supported by our cutting-edge technology, which can non-invasively monitor the course of the disease.

Arterial Spin Labeling (ASL) represents a modern MRI technique for measuring regional brain perfusion and permeability by modifying the magnetization of blood water protons to serve as natural tracers. This method is entirely non-invasive, eliminating the need for ionizing radiation or external contrast agents.

The non-invasive nature of ASL provides numerous benefits for clinical research: it allows for repeated cerebral blood flow (CBF) measurements as often as needed and is suitable for use in vulnerable groups, such as patients with renal failure, elderly individuals or Alzheimer’s patients.

World Parkinson’s Day

11. April 2025

Brain Perfusion & Parkinson’s: A Vital Connection

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, and understanding brain blood flow is key to improving diagnosis and treatment. Arterial Spin Labeling (ASL) MRI, a non-invasive perfusion imaging technique, provides valuable insights by measuring cerebral blood flow.

Early Detection – Identifies perfusion changes before significant symptoms appear.
Tracking Disease Progression – Monitors blood flow reductions in affected brain regions.
Optimizing Treatment – Helps assess therapy effectiveness and personalize care.
Advancing Research – Aids in drug development and deeper understanding of PD pathology.

ASL MRI is revolutionizing how we detect, monitor, and treat Parkinson’s, paving the way for more precise and effective interventions.

At mediri GmbH, we support you with sophisticated yet easy-to-use ASL image analysis tools, including specialized ASL sequences that can measure exchange time. Our services cover all aspects of ASL imaging.
As a one-stop-shop, we provide comprehensive evaluation services. We specialize in clinical trials that demand precise image data acquisition and quality assurance. Our services include image collection, quality checks, site support, and project management. Perfect for clinical trials requiring longitudinal imaging data or centralized reviews.

World Health Day 2025

07. April 2025

On this World Health Day, we emphasize the need for quality healthcare for women before, during, and after pregnancy and childbirth. Women’s health is a cornerstone of thriving families and communities.

At mediri, we take pride in being an employer that champions the health and well-being of our female employees. We are dedicated to creating a supportive workplace that nurtures their health.

Let’s unite in our efforts to ensure every woman receives the care she deserves. Together, we can create a healthier world!

What is ASL?

03. April 2025

Arterial Spin Labeling (ASL) represents a modern MRI technique for measuring perfusion, which modifies the magnetization of blood water protons to serve as natural tracers.
This method is entirely non-invasive, eliminating the need for ionizing radiation or external contrast agents.
The non-invasive nature of ASL provides numerous benefits for clinical research: it allows for repeated cerebral blood flow (CBF) measurements as often as needed and is suitable for use in vulnerable groups, such as patients with renal failure or pediatric patients.

Why It Matters: ASL offers a safe and effective way to measure cerebral perfusion, making it ideal for various clinical applications.

Have you heard about ASL before? Share your thoughts and experiences with us!

Interested in truly non-invasive BBB imaging?

12. March 2025

Are you interested in truly non-invasive BBB imaging? We are. That’s why we are investigating in Multi-Echo Arterial Spin Labeling MR imaging techniques (a.k.a. BBB ASL) that enable Tex brain maps.

If you are using ASL sequences for your research you will be familiar with CBF and ATT maps. Our cutting-edge MR sequences together with sophisticated mathematical models go beyond these and produce Tex maps, which show the microvascular exchange dynamics and promise to be an indicator for BBB integrity.

More research in this field is to come and will show how Tex can be used clinically in the future. Be part of this research: Contact us if you want to join us on this exciting journey! 

Not (yet) familiar with the wording? Here you go:

ASL Arterial Spin Labeling is a special MRI technique which uses magnetically labeled blood for perfusion measurements.
BBB Blood Brain Barrier… you have heard of that one.
CBF Cerebral Blood Flow is a measure for brain perfusion.
ATT Arterial Transit Time is the time taken from blood to travel from large arteries in the neck to the cerebral tissue.
Tex exchange Time serves as proxy for BBB permeability to water.

Meet our COO at the DGKN conference in Frankfurt

10. March 2025

Meet our COO Dr. Julia Müller in Frankfurt to discuss hot topics in Neuroimaging from Perfusion to BBB integrity.
How can we bring perfusion MRI into clinical application? How can we simplify the analysis of Arterial Spin Labeling MR images and provide sophistaced biomarkers for brain perfusion and micro-architecture? I am looking forward to discuss these topics with you at the DGKN e.V. Conference in Frankfurt this week.

Meet our CEO at ISMRM

06. March 2025

Meet our CEO Prof. Dr. Matthias Günther at ISMRM in Pamplona, Spain! 

Join us from 15-17 March 2025 at the ISMRM Workshop on Perfusion MRI and engage with our CEO, Prof. Dr. Matthias Günther. This workshop aims to disseminate cutting-edge research on perfusion MRI and related methods.

Engineers, scientists, and clinicians interested in perfusion MRI techniques and applications, from acquisition to processing strategies, are welcome to join us. Don’t miss this opportunity to connect and learn from the best in the field!

mediri is your dedicated partner for efficient and reliable imaging studies. As your one-stop shop, we provide everything you need – from planning to central read – all under one roof. Benefit from our unique combination of study experience and cutting-edge technological expertise. Our mTRIAL cloud platform enables seamless data exchange, maximum data security in Germany and AI-supported workflows tailored to your study.